Researchers analyzed data from 24 studies involving 408 animals, including 396 rodents and 12 canines, to see how emodin affects kidney health. The main goal was to measure changes in serum blood urea nitrogen and creatinine, which are common signs of kidney stress. The review also looked at kidney size as a secondary measure of health.
The analysis showed that emodin significantly reduced levels of blood urea nitrogen and creatinine across the studies. These markers are often used to track kidney function, and lower levels generally suggest less injury. However, the studies varied in how they gave the substance and how long they treated the animals.
Safety concerns emerged when animals received very high doses, over 1,000 mg per kilogram, or were treated for more than one month. Under these specific conditions, signs of toxicity were observed. The researchers noted that precise dosing and exposure control are essential for future development of emodin as a potential kidney treatment.
Readers should understand that these findings are limited to animals and cannot be directly applied to humans. More research is needed to determine if emodin is safe and effective for people with kidney problems. Until clinical trials are done, this information should not be used to change medical treatment plans.